F/m Emerald Life Sciences Innovation ETF
LFSC
7 hedge funds and large institutions have $75.5M invested in F/m Emerald Life Sciences Innovation ETF in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 7 → 7 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
12% less capital invested
Capital invested by funds: $85.7M → $75.5M (-$10.1M)
15.29% less ownership
Funds ownership: 92.21% → 76.92% (-15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCWP
Cedar Cove Wealth Partners
Bloomington,
Minnesota
|
+$2.48M |
| 2 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$793K |
| 3 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$136K |
| 4 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$105K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$3.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9.27M |
| 2 |
MML Investors Services
Springfield,
Massachusetts
|
-$498K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$449K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMFAT
1
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
| $69.9M | – | – | – |
|
|
CCWP
2
Cedar Cove Wealth Partners
Bloomington,
Minnesota
| $2.45M | +$2.48M | +69,994 | New |
|
|
HAIM
3
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
| $1.74M | +$136K | +3,831 | +8% |
|
|
AI
4
Atria Investments
Charlotte,
North Carolina
| $782K | +$793K | +22,345 | New |
|
|
TI
5
Tidal Investments
Milwaukee,
Wisconsin
| $698K | +$105K | +2,954 | +17% |
|
|
ASN
6
Advisory Services Network
Atlanta,
Georgia
| $3.5K | +$3.55K | +100 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $735 | -$11.5K | -324 | -94% |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$9.27M | -253,148 | Closed |
|
|
9
MML Investors Services
Springfield,
Massachusetts
| – | -$498K | -13,592 | Closed |
|
|
10
Envestnet Asset Management
Chicago,
Illinois
| – | -$449K | -12,267 | Closed |
|
LFSC Hedge Fund Activity: Q1 2026 in Review
7 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q1 2026, worth a combined $75.5M — down 12% from $85.7M a quarter earlier.
Fund positioning in LFSC was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Cedar Cove Wealth Partners, opening a new position worth an estimated $2.48M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $9.27M sold.
- 7 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $75.5M of F/m Emerald Life Sciences Innovation ETF stock for Q1 2026, down 12% quarter-over-quarter.
- 3 funds opened new F/m Emerald Life Sciences Innovation ETF positions in Q1 2026 and 3 closed out, a net change of 0 holders.
- The largest F/m Emerald Life Sciences Innovation ETF buyer in Q1 2026 was Cedar Cove Wealth Partners, an estimated $2.48M added.
- The largest F/m Emerald Life Sciences Innovation ETF seller in Q1 2026 was Susquehanna International Group, an estimated $9.27M sold.
Based on aggregated 13F filings for Q1 2026.